Pharmaceutical Supply – Calcium Chloride Injection (NSN: 6505015037386)

The contract obligates the supplier to manufacture and deliver sterile Calcium Chloride Injection that meets FDA approval and USP compliance standards, specifically aligned with the National Stock Number 6505015037386, for issuance to a U.S. Navy vessel. The product must adhere strictly to military specifications for sterile injectables, ensuring purity, potency, and packaging criteria required for naval medical use. The supply is governed under a subcontract arrangement with the Defense Logistics Agency acting on behalf of the Department of Defense, and production must comply with all regulatory and quality assurance protocols applicable to pharmaceuticals intended for military medical operations. The item falls under NAICS Code 325412, which categorizes it within the pharmaceutical and medicinal preparation manufacturing sector, and the delivery will occur to a U.S. Navy vessel as the designated place of performance. Although no specific city or state is provided for the place of performance, the contractual obligation is to ensure supply reaches operational naval assets. The contract was posted on August 5, 2026, with a reference to the award document SPE2DX25D8022 and delivery order SPE2D926F7947, indicating an active procurement under the DLA's system. There is no public point of contact listed, and the solicitation details are restricted to the internal defense supply chain process, underscoring the sensitivity and operational nature of the procurement.